NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 24, Pages E2443-E2452
Publisher
Proceedings of the National Academy of Sciences
Online
2014-06-03
DOI
10.1073/pnas.1404269111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling
- (2013) Laurent Mouchiroud et al. CELL
- NAD+ acts on mitochondrial SirT3 to prevent axonal caspase activation and axonal degeneration
- (2013) Sébastien Magnifico et al. FASEB JOURNAL
- Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors
- (2013) Ubaldina Galli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multiparametric Analysis of CLASP-Interacting Protein Functions during Interphase Microtubule Dynamics
- (2013) J. B. Long et al. MOLECULAR AND CELLULAR BIOLOGY
- The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity
- (2012) Carles Cantó et al. Cell Metabolism
- EB1-Recruited Microtubule +TIP Complexes Coordinate Protrusion Dynamics during 3D Epithelial Remodeling
- (2012) Sarah Gierke et al. CURRENT BIOLOGY
- Axon degeneration: Molecular mechanisms of a self-destruction pathway
- (2012) Jack T. Wang et al. JOURNAL OF CELL BIOLOGY
- Calorie Restriction and SIRT3 Trigger Global Reprogramming of the Mitochondrial Protein Acetylome
- (2012) Alexander S. Hebert et al. MOLECULAR CELL
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Proteomic Investigations of Lysine Acetylation Identify Diverse Substrates of Mitochondrial Deacetylase Sirt3
- (2012) Eri Maria Sol et al. PLoS One
- Mitochondrial sirtuins: regulators of protein acylation and metabolism
- (2012) Wenjuan He et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas
- (2011) UFFE HØGH OLESEN et al. APMIS
- Signal transduction by reactive oxygen species
- (2011) Toren Finkel JOURNAL OF CELL BIOLOGY
- Taxol Facilitates Axon Regeneration in the Mature CNS
- (2011) V. Sengottuvel et al. JOURNAL OF NEUROSCIENCE
- The SirT3 Divining Rod Points to Oxidative Stress
- (2011) Eric L. Bell et al. MOLECULAR CELL
- Pharmacological Effects of Exogenous NAD on Mitochondrial Bioenergetics, DNA Repair, and Apoptosis
- (2011) M. Pittelli et al. MOLECULAR PHARMACOLOGY
- SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production
- (2011) E L Bell et al. ONCOGENE
- Microtubule Stabilization Reduces Scarring and Causes Axon Regeneration After Spinal Cord Injury
- (2011) F. Hellal et al. SCIENCE
- Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
- (2011) J. Du et al. SCIENCE
- Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric Restriction
- (2010) Shinichi Someya et al. CELL
- Calorie Restriction Reduces Oxidative Stress by SIRT3-Mediated SOD2 Activation
- (2010) Xiaolei Qiu et al. Cell Metabolism
- Inhibition of Cell Migration and Cell Division Correlates with Distinct Effects of Microtubule Inhibiting Drugs
- (2010) Hailing Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Nicotinamide Phosphoribosyltransferase
- (2010) Maria Pittelli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability
- (2010) Claudio R. Thoma et al. JOURNAL OF CELL BIOLOGY
- Metabolomic Analysis of Livers and Serum from High-Fat Diet Induced Obese Mice
- (2010) Hyun-Jin Kim et al. JOURNAL OF PROTEOME RESEARCH
- Analysis of microtubule dynamic instability using a plus-end growth marker
- (2010) Alexandre Matov et al. NATURE METHODS
- The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration
- (2010) Gerd Meyer zu Horste et al. NEUROBIOLOGY OF DISEASE
- NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response
- (2010) B Wang et al. ONCOGENE
- Sirtuin 3, a New Target of PGC-1α, Plays an Important Role in the Suppression of ROS and Mitochondrial Biogenesis
- (2010) Xingxing Kong et al. PLoS One
- Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
- (2009) Anne von Heideman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Nicotinamide Mononucleotide Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not Increased Levels of Neuronal Nicotinamide Adenine Dinucleotide
- (2009) Y. Sasaki et al. JOURNAL OF NEUROSCIENCE
- Axonal elongation triggered by stimulus-induced local translation of a polarity complex protein
- (2009) Ulrich Hengst et al. NATURE CELL BIOLOGY
- A New Splice Variant of the Mouse SIRT3 Gene Encodes the Mitochondrial Precursor Protein
- (2009) Helen M. Cooper et al. PLoS One
- Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1
- (2009) Y. Nakahata et al. SCIENCE
- The human SIRT3 protein deacetylase is exclusively mitochondrial
- (2008) Helen M. Cooper et al. BIOCHEMICAL JOURNAL
- TheWldSgene delays axonal but not somatic degeneration in a rat glaucoma model
- (2008) Bogdan Beirowski et al. EUROPEAN JOURNAL OF NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More